Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer
{{output}}
Intravesical mitomycin C (MMC) is a cornerstone therapy for non-muscle-invasive bladder cancer (NMIBC), effectively reducing recurrence in low-grade intermediate-risk patients. We conducted a narrative synthesis of randomized and prospective studies evaluating... ...
